ArticleHealth economics review2025
Two-year retrospective review of costs associated with COVID-19 case management in Regina, Saskatchewan.
Article in Health economics review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 pandemic, declared in March 2020, caused significant morbidity and mortality globally. This study aims to estimate the costs associated with managing COVID-19 infected patients in Regina.
methodThe study focuses on the direct and indirect healthcare costs of managing a COVID-19 case. Costing elements included are diagnostic, public health, inpatient and outpatient management costs. The costing analysis estimates the total cost of COVID-19 case management in Regina, the average cost per case based on disease severity, and the costs for diagnostics, public health management, and clinical areas.
resultsSevere cases, representing 1.3% of cases, accounted for a quarter of the total cost of illness, while moderate cases (1.8%) contributed to less than 5% of the overall cost. Mild cases (96.9%) were responsible for three-quarters of the associated illness costs. Over two years, approximately $85 million was spent on the care of 28,733 cases, primarily due to hospitalization costs. Annual per-patient expenses increased from $45 in 2020 to $183 in 2021, reflecting a higher case burden and greater health care utilization. Furthermore, the Omicron variant accounted for 44% of the disease burden and 36% of the illness costs. Patients older than 80 accounted for 10% of illness costs, while children aged less than 18 accounted for about 17%.
conclusionThe primary costs were human resources and hospitalizations for older individuals, significantly impacting the Saskatchewan Health Authority's budget due to the pandemic. This analysis does not fully capture the effects in Regina.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.